Måndag 28 September | 22:59:09 Europe / Stockholm
Est. tid*
2027-01-29 08:00 Bokslutskommuniké 2026
2026-10-30 08:00 Kvartalsrapport 2026-Q3
2026-07-31 - Kvartalsrapport 2026-Q2
2026-05-21 - Årsstämma
2026-05-08 - X-dag ordinarie utdelning MPOS 0.00 SEK
2026-04-30 - Kvartalsrapport 2026-Q1
2026-01-30 - Bokslutskommuniké 2025
2025-10-31 - Kvartalsrapport 2025-Q3
2025-07-31 - Kvartalsrapport 2025-Q2
2025-05-21 - Årsstämma
2025-05-21 - Kvartalsrapport 2025-Q1
2025-05-09 - X-dag ordinarie utdelning MPOS 0.00 SEK
2025-01-30 - Bokslutskommuniké 2024
2024-10-31 - Kvartalsrapport 2024-Q3
2024-07-31 - Kvartalsrapport 2024-Q2
2024-05-30 - X-dag ordinarie utdelning MPOS 0.00 SEK
2024-05-29 - Årsstämma
2024-04-30 - Kvartalsrapport 2024-Q1
2024-01-31 - Bokslutskommuniké 2023
2023-10-26 - Kvartalsrapport 2023-Q3
2023-07-27 - Kvartalsrapport 2023-Q2
2023-05-25 - Årsstämma
2023-05-05 - X-dag ordinarie utdelning MPOS 0.00 SEK
2023-04-27 - Kvartalsrapport 2023-Q1
2023-01-30 - Bokslutskommuniké 2022
2022-11-14 - Extra Bolagsstämma 2022
2022-10-27 - Kvartalsrapport 2022-Q3
2022-07-28 - Kvartalsrapport 2022-Q2
2022-05-09 - X-dag ordinarie utdelning MPOS 0.00 SEK
2022-04-28 - Kvartalsrapport 2022-Q1
2022-02-28 - Bokslutskommuniké 2021
2021-08-31 - Kvartalsrapport 2021-Q2
2021-05-03 - X-dag ordinarie utdelning MPOS 0.00 SEK
2021-02-18 - Bokslutskommuniké 2020
2020-08-31 - Kvartalsrapport 2020-Q2
2020-05-28 - X-dag ordinarie utdelning MPOS 0.00 SEK
2020-05-27 - Årsstämma
2020-02-28 - Bokslutskommuniké 2019
2019-11-04 - Extra Bolagsstämma 2019
2019-08-30 - Kvartalsrapport 2019-Q2
2019-05-23 - X-dag ordinarie utdelning MPOS 0.00 SEK
2019-05-22 - Årsstämma
2019-02-28 - Bokslutskommuniké 2018
2018-08-30 - Kvartalsrapport 2018-Q2
2018-06-01 - X-dag ordinarie utdelning MPOS 0.00 SEK
2018-05-31 - Årsstämma
2018-02-28 - Bokslutskommuniké 2017
2017-08-30 - Kvartalsrapport 2017-Q2
2017-05-26 - X-dag ordinarie utdelning MPOS 0.00 SEK
2017-05-24 - Årsstämma
2017-02-28 - Bokslutskommuniké 2016
2016-09-15 - Extra Bolagsstämma 2016
2016-08-30 - Kvartalsrapport 2016-Q2
2016-05-31 - Årsstämma
2016-05-12 - X-dag ordinarie utdelning MPOS 0.00 SEK
2016-02-29 - Bokslutskommuniké 2015
2015-08-27 - Kvartalsrapport 2015-Q2
2015-05-12 - X-dag ordinarie utdelning MPOS 0.00 SEK
2015-05-11 - Årsstämma
2015-03-10 - Extra Bolagsstämma 2015
2015-02-27 - Bokslutskommuniké 2014
2014-08-29 - Kvartalsrapport 2014-Q2
2014-05-19 - X-dag ordinarie utdelning MPOS 0.00 SEK
2014-05-16 - Årsstämma
2014-02-28 - Bokslutskommuniké 2013
2013-10-25 - Extra Bolagsstämma 2013
2013-08-29 - Kvartalsrapport 2013-Q2
2013-05-24 - X-dag ordinarie utdelning MPOS 0.00 SEK
2013-05-23 - Årsstämma
2012-12-20 - Extra Bolagsstämma 2012
2012-08-29 - Kvartalsrapport 2012-Q2
2012-05-24 - X-dag ordinarie utdelning MPOS 0.00 SEK
2012-05-23 - Årsstämma
2012-02-29 - Bokslutskommuniké 2011
2012-02-28 - Bokslutskommuniké 2012
2011-08-25 - Kvartalsrapport 2011-Q2
2011-05-20 - X-dag ordinarie utdelning MPOS 0.00 SEK
2011-05-19 - Årsstämma
2011-02-24 - Bokslutskommuniké 2010
2010-05-21 - X-dag ordinarie utdelning MPOS 0.00 SEK
LandSverige
ListaSpotlight
SektorHälsovård
IndustriMedicinteknik
Micropos Medical är verksamt inom medicinteknik. Bolagets produkter används inom strålbehandling. Visionen är att utveckla en teknik som skall precisera sjukdomar vid nämnd behandling, där produktutvecklingen baseras på elektromagnetiskt positionssystem. Produkten skapar realtidsinformation och används främst för behandling av prostatacancer, men även vid andra tumörbehandlingar. Bolaget etablerades 2003 och har sitt huvudkontor i Göteborg.

Analysera bolaget i Börsdata!

All ägardata du vill ha finns i Holdings!

Micropos Medical: Hospital Meixoeiro do Vigo in Spain Treats Its First Patient with the Raypilot® System

2026-09-25 11:50:00

Hospital Meixoeiro do Vigo in Spain, has treated its first prostate cancer patient using Augmented Stereotactic Body Radiation Therapy (ASBRT) with support of the Raypilot System®. The treatment follows the installation of the system and training of the clinical team, expanding access to advanced radiotherapy techniques in the region.

Following the signing of a rental agreement with the hospital, installation of the system and staff training were completed earlier this year and on September 14, the clinical team initiated its first patient treatment, marking the start of a new chapter in precision radiotherapy at the hospital.

Growing Adoption Across Spain
The implementation of the Raypilot System at Hospital Meixoeiro do Vigo adds to a growing number of Spanish hospitals introducing real-time prostate tracking as part of a modern radiotherapy workflow. The hospital joins other centers across the country that have adopted the technology for prostate cancer treatment and becomes the sixth Spanish customer to implement the Raypilot System in the country.

Dr. Patricia Willisch, Head of Radiation Oncology at the hospital, commented:
"Compared with previous approaches, the process is much easier for the patient. The technique involves placing a minimally invasive transperineal device that enables treatment with very small margins and allows patients to receive treatment on an outpatient basis over just a few days."

Real-Time Tracking Improves Treatment Confidence
From a medical physics perspective, the implementation of Raypilot integrates smoothly into existing radiotherapy workflows while providing a significant advantage through continuous prostate motion monitoring.

Benito Andrade, Medical Physicist at Hospital Meixoeiro, Vigo, Spain, said:
"From a physics perspective, the workflow is very similar to other image-guided radiotherapy techniques. Treatment planning, dose constraints and patient setup remain largely unchanged. The key difference is the ability to continuously track the prostate throughout treatment."

Dr. Willisch added:
"With this system, we always know the position of the prostate during treatment. If movement occurs, treatment can be paused and resumed once the prostate returns to the intended position. This continuous monitoring allows us to maintain very small treatment margins while ensuring accurate dose delivery. It provides a high level of confidence for both clinicians and patients and is a effective solution for treatment management and delivery."

Advancing Modern Radiation Therapy
Micropos Medical continues its efforts to increase awareness of modern radiation therapy as an effective, precise and patient-friendly treatment option for prostate cancer. 

Strong clinical evidence supports the use of advanced radiotherapy techniques to achieve good treatment outcomes while minimizing the risk of side effects and reducing the treatment burden for patients. The collaboration with Hospital do Meixoeiro de Vigo strengthens access to modern treatment approaches in the region and supports the broader ambition of making accurate and high-precision radiotherapy available to more prostate cancer patients.